- Trials with a EudraCT protocol (600)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
600 result(s) found for: Testosterone.
Displaying page 1 of 30.
EudraCT Number: 2013-005135-24 | Sponsor Protocol Number: ECDOPDEP2013 | Start Date*: 2014-03-21 | |||||||||||
Sponsor Name:Cristina Fernandez Pérez | |||||||||||||
Full Title: Clinical Trial crossed athletic population according UGT2B17 polymorphism. Impact on the steroid profile | |||||||||||||
Medical condition: Sports doping | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002102-73 | Sponsor Protocol Number: 171178 | Start Date*: 2012-02-17 | ||||||||||||||||
Sponsor Name:Endokrinologisk afd. M | ||||||||||||||||||
Full Title: Testosterone therapy of patients with type 2 diabetes mellitus | ||||||||||||||||||
Medical condition: Type 2 diabetes mellitus (T2DM) is a common endocrine disorder caracterized by hyperinsulinaemia and insulin resistance. We aim to investigate if testosterone therapy can improve body composition, ... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-004430-96 | Sponsor Protocol Number: 201600107 | Start Date*: 2017-12-11 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Short-term Testosterone replacement in testicular cancer survivors to treat overweight and improve cardiometabolic risk | ||
Medical condition: Testicular cancer | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004866-16 | Sponsor Protocol Number: I5E-MC-TSAT | Start Date*: 2013-06-06 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Parallel Study with an Open-Label Extension to Assess the Impact of Testosterone Solution on Total Testosterone, Sex Drive and Energy in Hypogonadal Men. | |||||||||||||
Medical condition: Male hypogonadism | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) IT (Completed) GB (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001767-23 | Sponsor Protocol Number: T01/09/13 | Start Date*: 2016-02-29 | |||||||||||||||||||||
Sponsor Name:Seahorse Scientific Services Ltd. | |||||||||||||||||||||||
Full Title: A Single-Dose, Single Period, Phase II Pharmacokinetic Study To Examine TDS®-Testosterone For Its Potential To Be Inadvertently Transferred By Skin Contact After Dosing In Healthy Adult Subjects | |||||||||||||||||||||||
Medical condition: Male Hypogondism | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001766-42 | Sponsor Protocol Number: D1/09/13 | Start Date*: 2016-03-09 | |||||||||||||||||||||
Sponsor Name:Seahorse Scientific Services Ltd. | |||||||||||||||||||||||
Full Title: A Multiple-Dose, Single Period, Phase II Dose Ranging Study to Examine Testagen™ TDS®-Testosterone 5% in Adult Male Subjects | |||||||||||||||||||||||
Medical condition: Male Hypogondism | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000291-42 | Sponsor Protocol Number: TEST-DM1 | Start Date*: 2012-10-05 |
Sponsor Name:Consorci Mar Parc de Salut de Barcelona (Parc de Salut Mar) | ||
Full Title: Effect of treatment with testosterone undecaonat in patients with Diabetes Mellitus Type 1 (DM-1) and hipogonadotrophic hypogonadism | ||
Medical condition: Diabetes Mellitus Type 1 (DM-1) and hipogonadotrophic hypogonadism | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-001452-30 | Sponsor Protocol Number: 010815testis | Start Date*: 2015-12-07 | |||||||||||
Sponsor Name:Copenhagen University Hospital Rigshospitalet | |||||||||||||
Full Title: A Randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig Cell Insufficiency (Einstein-intervention) | |||||||||||||
Medical condition: Leydig Cell dysfunction | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-020018-27 | Sponsor Protocol Number: Dbox2008/01978 | Start Date*: 2012-04-19 |
Sponsor Name:Tameside Hospital NHS Foundation Trust | ||
Full Title: Effect of Testosterone on endothelial function and Microcirculation in Type 2 Diabetic patients with Hypoganadism. | ||
Medical condition: Hypogonadism and erectile dysfunction in patients with type 2 diabetes | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001751-12 | Sponsor Protocol Number: vitDdiab | Start Date*: 2018-12-05 |
Sponsor Name:uz brussels | ||
Full Title: Vitamin D Supplementation to increase free testosterone in Type 2 Diabetes Mellitus men: a Placebo-controlled Randomized Clinical Trial | ||
Medical condition: type 2 diabetes testosteron < 11 nmol/L | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2006-006925-26 | Sponsor Protocol Number: no sponsor | Start Date*: 2007-04-05 |
Sponsor Name:Rijnstate hospital | ||
Full Title: Optimalising the Androgen-Oestrogen Balance in Testosterone Substituted Hypogonadal Men by Aromatase Inhibition. | ||
Medical condition: Men with hypogonadotropic hypogonadism treated with testosterone substitution | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-000931-16 | Sponsor Protocol Number: 1054 | Start Date*: 2008-08-05 |
Sponsor Name:Dr G I Hackett | ||
Full Title: 1054 -FINAL VERSION 30th Dec 2007 Clinical and biochemical improvement in Type 2 diabetic parameters in type 2 diabetic men with symptomatic testosterone deficiency syndrome (TDS). A double blind... | ||
Medical condition: Male Type 2 diabetics with symptomatic testosterone deficiency and confirmed low levels of serum testosterone | ||
Disease: | ||
Population Age: | Gender: | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003652-35 | Sponsor Protocol Number: 300 | Start Date*: 2006-02-02 |
Sponsor Name:Barnsley Hospital NHS Foundation Trust | ||
Full Title: A randomised, double blind, placebo controlled study to assess the effect of testosterone treatment on arterial stiffness in patients with type 2 diabetes, peripheral vascular disease and hypogonad... | ||
Medical condition: Male Hypogonadism | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-004266-15 | Sponsor Protocol Number: ARYHM-1 | Start Date*: 2012-01-18 | |||||||||||
Sponsor Name:RMC, Skåne University Hospital | |||||||||||||
Full Title: Androgen replacement in young hypogonadal men: a 2 year randomized, double-blind placebo controlled study | |||||||||||||
Medical condition: Target population: Male hypogonadism (testosterone deficiency) As end points Bone mineralisation Body composition Markers of insulin sensitivity and cardiovascular disease Lipid profile H... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: SE (Ongoing) NO (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002140-22 | Sponsor Protocol Number: Vitality | Start Date*: 2020-11-02 | |||||||||||
Sponsor Name:Lars møller Pedersen | |||||||||||||
Full Title: Gonadal dysfunction in male long-term survivors of malignant lymphoma | |||||||||||||
Medical condition: Hypogonadism | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003012-27 | Sponsor Protocol Number: 18062020 | Start Date*: 2021-01-12 |
Sponsor Name:Canisius Wilhelmina Ziekenhuis | ||
Full Title: Impact of peri-operative tEstosterone levels oN Functional and oncological Outcomes following RadiCal prostatEctomy | ||
Medical condition: Late-onset hypogonadism | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005139-61 | Sponsor Protocol Number: EB064 | Start Date*: 2006-10-24 |
Sponsor Name:Emotional Brain | ||
Full Title: Neural correlates of sexual arousal during treatment of testosterone combined with sildenafil in healthy female subjects with FSD. Effects of differing levels of attentional engagement on neural co... | ||
Medical condition: Hypoactive sexual desire disorder and female sexual arousal disorder | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2005-000049-12 | Sponsor Protocol Number: STH13889 | Start Date*: 2005-03-07 |
Sponsor Name:Sheffield teaching Hospitals NHS Foundation Trust | ||
Full Title: The effects of testosterone therapy in men with pulmonary hypertension | ||
Medical condition: Pulmonary Hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-004978-34 | Sponsor Protocol Number: RBHP2017BACHOUMAS | Start Date*: 2018-12-04 |
Sponsor Name:CHU de Clermont-ferrand | ||
Full Title: Efficacy of Testosterone gel to restore normal serum values of testosterone during the acute phase of critical illness in adult ICU patients. An open-label parallel randomized controlled pilot study | ||
Medical condition: - Hypermetabolism in ICU, loss of muscle mass and functional disability after ICU - ICU acquired hypogonadism - Treatment with testosterone gel in ICU | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-005179-10 | Sponsor Protocol Number: ISS16694 | Start Date*: 2015-07-27 |
Sponsor Name:Charalampos Vlachopoulos | ||
Full Title: Effect of long-term testosterone replacement therapy on arterial stiffness and endothelial function in male patients with hypogonadism | ||
Medical condition: Male patients with hypogonadism | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: GR (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
